| INTRODUCTION
Hemangiosarcoma (HSA) represents approximately 5% of all noncutaneous primary malignant neoplasms and 12% to 21% of all mesenchymal neoplasms in the dog. 1 Hemangiosarcoma is a neoplasm of vascular endothelial origin that potentially can affect any anatomic site either as a primary or metastatic tumor. 2 It is characterized by aggressive biological behavior because of its high metastatic potential, which leads to a poor prognosis. 3 Hemangiosarcoma affects most every breeds, but, German Shepherd Dogs, Golden Retrievers, Labrador
Retrievers, and Schnauzers are predisposed. 4 Males seem to have a higher risk of developing HSA than do females. 5 In the dog, the most common primary site is the spleen, and the most frequent metastatic sites are the liver, omentum, mesentery, and lungs. 1 The presence of primary HSA in other tissues such as liver, right atrium, mesentery, kidney, muscle, skin, subcutaneous tissue, conjunctiva, as well as intrathoracic, retroperitoneal, and epidural spaces has been described. 4, [6] [7] [8] [9] [10] [11] [12] Skeletal muscular metastases (SMMs), although uncommon, previously have been described in dogs and cats and have been mainly reported in the limbs. 10, [13] [14] [15] [16] Skeletal muscular metastases have been considered rare in humans, typically occurring late in the disease course and representing <5% of all cases of systemic metastasis. 17 In humans, the most common malignancy metastasizing to the skeletal musculature is lung cancer, followed by gastrointestinal cancer and renal cell carcinoma with the most commonly reported metastatic sites being the paraspinal muscles and skeletal muscles of the lower extremities. 17, 18 The rare occurrence of metastasis to skeletal muscle suggests that this organ may be in fact a hostile environment for tumor emboli. 17 As a consequence, SMMs may progress more slowly than tumor deposits elsewhere in the body or present later in the disease course. 19 Presence of SMMs supports a poor prognosis because their detection indicates widespread metastatic disease (stage III). 1 In veterinary medicine, the use of ultrasound to detect SMMs in a dog with splenic and cardiac HSA has been described previously. 20 Another study described the use of whole body computed tomography (CT) to detect muscular metastatic lesions from a range of primary malignant neoplasms and to guide tissue sampling. 16 Our aims were to describe the prevalence, distribution, and clinical characteristics of SMMs in dogs with HSA.
| MATERIALS AND METHODS

| Experimental design
The study was a multicenter retrospective study. Hospital, all the patients were ventilated, whereas at Pet Care Veterinary Association and Blucenter Veterinary Clinic, the animals were maintained on spontaneous ventilation.
All of the studies were acquired in helical scan mode and with slice thickness of 1 mm. Contrast-enhanced images were obtained using SMMs were present >1 group, they were considered as "multiple site"
metastases. Presence and localization of other metastatic lesions also were evaluated.
In the event of disparity in any of these characteristics, a consensus was reached by review of the images by both radiologists.
| Ethics
All animals included in the study were client-owned and for each case an 
| Statistics
Mean, SD, range, and frequencies were used as descriptive statistics.
Logistic regression was applied to identify factors significantly associated with SMMs and odds ratios (ORs) and their 95% confidence intervals (95% CI) were computed. Age, sex, neuter status, breed, primary tumor location and dimension, and additional metastatic sites were the putative factors considered for logistic regression analysis.
The Fisher exact test was used instead of logistic regression when null frequency occurred and no OR could be determined. Data were analyzed using the SPSS Statistics package (IBM Co., Armonk, New York;
Version 23) and 2-tailed P values <.05 were considered significant.
| RESULTS
Sixty-one dogs of 21 different breeds met the inclusion criteria. The mean age was 10.3 ± 2.2 years (range, 4-15 years), 39 (63.9%) were males (6/39, 15.4% neutered) and 22 (36.1%) were females (9/22, 40.9% spayed) with a total of 15 (24.6%) animals that were sterilized.
Crossbreed (n = 20, 32.8%), Golden/Labrador Retriever (n = 10, 16.4%),
German Shepherd (n = 6, 9.8%), and Boxer (n = 6, 9.8%) were most commonly affected. The presumed primary tumor was located in spleen (n = 40, 65.6%), liver (n = 9, 14.8%), muscles (n = 5, 8.2%), and peritoneum (n = 4, 6.6%), as well as in right atrium, kidney, and mediastinum (n = 1, 1.6% each). The diameter of the primary lesion (mean, were the most frequent sites (Table 1) .
| Prevalence of skeletal muscle metastasis
Skeletal muscle metastases were detected in 15 of 61 dogs (24.6%). Table 2 shows the prevalence of metastases according to the characteristics of the 61 HSA dogs. Presence of SMMs was significantly higher in males (35.9% versus 4.5%; OR, 11.8; P = .02) whereas age (P = .16), neuter status (P = .64), breed (P = .55) as well as localization (P = .82) and dimension of the presumed primary tumor (P = .69)
were not significantly different between dogs with and without SMMs. 
| Clinical signs
Clinical signs were recorded in 57 of the 61 animals included in the study. Nine (60.0%) of the 15 dogs with SMMs showed signs of lameness or were reluctant to move whereas none of the 42 dogs without
SMMs showed musculoskeletal signs (P < .001; Table 3 ). In these 9 dogs, 
| DISCUSSION
In dogs, HSA may be solitary, multifocal within an organ, or widely disseminated at presentation and because of its intimate association with the vasculature, facilitating extravasation and angiogenesis of metastatic clones, it is typified by very aggressive biologic behavior, with rapid and widespread metastasis occurring frequently. 1 In our study population, we found that the prevalence of SMMs in dogs with HSA was higher in comparison with previously published studies in the human and veterinary medical literature. 16, 17, 22 The higher prevalence of SMM in our cohort may reflect some selection bias and may be higher than that seen in all dogs with HSA. Clients may have opted for euthanasia of patients with radiologically overt metastasis, inoperable primary lesions, or clinically relevant comorbidities.
We found that 46 of 61 dogs with HSA had additional metastatic sites with spleen, liver, and lungs being most common, consistent with previous reports in the veterinary literature.
1,7,23
As previously observed, 10,23-25 no statistical correlation was found in our study between the dimension of the primary tumor and the presence of metastasis, meaning that the size of the primary tumor alone cannot be used to estimate biological behavior, and even small tumors could result in widespread metastatic disease.
In humans, SMMs can be observed on CT with 5 types of lesion: intramuscular mass (type I), abscess-like intramuscular lesion (type II), diffuse metastatic muscle infiltration (type III), multiple muscle calcification (type IV), and intramuscular bleeding (type V). 26 The tomographic features of SMMs in our study were variable, as has been reported with SMMs from several primary tumor types. Metastases can appear as ring-enhancing lesions with a hypodense necrotic center, heterogeneous nodules, hyperdense nodules, and as areas of multifocal intramuscular mineralization. 16 The radiological patterns of SMMs in our population had multiple features in common with the enhancement characteristics described in nonparenchymal HSA such as ring enhancement or heterogeneous contrast enhancement. 12 These 2 patterns most often were observed in our population whereas intralesional mineralization was less common. Because of the retrospective F I G U R E 2 Same dog as in Figure 1 . Diffuse SMMs with varied enhancement patterns are visible F I G U R E 1 A, Transverse and B, sagittal contrast-enhanced computed tomographic images of an 11-years-old neutered male cross-breed dog with a hemangiosarcoma metastasis in the tongue muscle. The lesion appears round, heterogeneous, and with mild ring enhancement nature of our study, it was not possible to obtain the exact percentage of each pattern, and further prospective studies are warranted.
Muscular metastases in veterinary patients have been described in cases of carcinoma, sarcoma, lymphoma, and mast cell tumor. [13] [14] [15] [16] 27, 28 In 1 study, sarcomas were highly represented with HSA being the most common subtype. 16 In our study, the presence of SMMs associated with HSA was significantly higher in males. This finding may reflect that males are slightly predisposed to HSA. 1, 5, 7, 25, 29 Males may be predisposed to SMMs, but a larger group of patients would be necessary to assess any possible differences in the rate of SMMs between sexes. No correlation was found between SMMs and age of the dogs included in our study even though HSA is mostly described in middle-aged to older animals. 1, 7, 25 This finding may be a consequence of the limited number of dogs with SMMs in our study. We did not find any correlation between the presence of SMMs and breed, although German Shepherds, Labrador Retrievers, and Boxers were most common, as they are in most veterinary studies on HSA. 1, 7, 25, 30 In our cohort of 61 dogs with HSA, all of the patients with SMMs (15/15, 100%) also had additional metastases in ≥1 site, representing an advanced stage of the disease and this data was found to be statistically significant. Because SMMs are considered distant metastases, their presence places these patients in a higher stage of disease (stage III), according to the "Clinical Staging System for Canine
Hemangiosarcoma." 1 This is consistent with previous reports in human medicine that describe the presence of muscle metastasis as a late event in the clinical progression of the disease. 17, 19 In fact, SMMs may progress more slowly than tumor deposits elsewhere in the body or present later in the course of the disease because of different mechanisms such as contractile activity, local alteration in pH, intramuscular blood pressure, accumulation of metabolites, and local temperature. 19 On the other hand, in dogs, the presence of SMMs may be a reflection of an aggressive neoplasm with early metastasis rather than late or chronic disease.
We found a significant correlation between SMMs and metastatic lesions in bone, lungs, and kidneys. We hypothesize this findings could be related to the fact that metastases in these sites remain subclinical for a longer time than do metastases, to other sites, such us liver or spleen, which can be associated with rupture and hemorrhage, usually leading to euthanasia early in the disease course. 31 In addition, we did not find a statistical correlation between the presence of SMMs and the presence of neoplastic cells within abdominal effusion.
Signs such as anorexia and lethargy are nonspecific and could be related to primary or metastatic HSA or concurrent unrelated illness. In our study, some of the major clinical signs were lameness and reluctance to move and were reported as the primary presenting complaint been described in the veterinary literature. 16 In people, the most frequent clinical sign of muscular metastasis is localized muscle pain, swelling, or both. 17 One dog with diffuse SMMs also had a SMM in tongue muscle. In addition to a SMM in the epaxial muscles, another patient had a single small (4 mm) pulmonary metastasis ( Figure 3 ).
These findings support the use of whole body contrast-enhanced computed tomography (CECT) to help with staging oncologic patients, and to better characterize pulmonary or non-pulmonary metastatic lesions.
In 1 study, ultrasound diagnosis of metastasis in the skeletal musculature of the thoracic wall was described in a dog with splenic and cardiac HSA, but deeper muscles were difficult to visualize with sufficient resolution because of the reflection or absorption of sound by superficial tissue layers, and ultrasound survey of the skeletal muscles is impractical. 20, 32 In human medicine, positron emission tomography (PET) has been described for detecting SMMs. 33, 34 In a recent study in humans, the detection rate of SMMs by PET was 100% (51/51), whereas that of CT was 23.5% (12/51). F-fluoro-2-deoxyglucose-PET-CT has been described as a promising tool for staging and monitoring of dogs with HSA, 41 but to our knowledge, no studies using PET-CT to detect SMMs in dogs have been reported.
The primary limitation to our study is its retrospective nature.
Another limitation is the possibility of missed lesions from lack of sensitivity of CT. In some of the dogs included in the study, it was difficult to distinguish between the primary tumor and metastatic lesions. In those cases, we considered as primary lesions those with consistent epidemiological, clinical, and also radiological findings (eg, common primary sites, presenting signs related to affected organ, disparity in number, and size of lesions). We acknowledge that we cannot know for sure which lesion is the primary lesion in all cases.
Computed tomography is widely available and has been recommended for evaluation of patients with malignant neoplasia with potential for lung metastases. [42] [43] [44] We believe that whole body CECT 
| CONCLUSION
In our study population, HSA had a high prevalence of SMMs. Most of the dogs with SMMs (60%) showed lameness or reluctance to move with an inconclusive neurologic or orthopedic examination. The remaining 40% were clinically silent with no attributable signs. Thus, whole body CECT, with histological or cytological sample collection, may be helpful in staging dogs with HSA and unspecified lameness. Moreover, because HSA is a tumor with a high metastatic rate, we believe CECT is likely the best widely available imaging modality to detect metastasis to lungs, muscle, and other sites. August-03rd September 2016.
